Hepatitis B virus genotype and mutants: risk factors for hepatocellular carcinoma.
Llovet
Josep M
JM
Lok
Anna
A
D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology*; D005060:Europe / Q000453:epidemiology; D005202:Asia, Eastern / Q000453:epidemiology; D005787:Gene Frequency; D005838:Genotype; D006509:Hepatitis B / Q000150:complications* / Q000188:drug therapy; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000235:genetics* / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology*; D009154:Mutation; D018570:Risk Assessment; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens